Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and other diseases, today announced the publication online of Part 1 results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback